Next Article in Journal
Prognostic Value of TH1/TH2 Cytokines in Infants with Wheezing in a Three Year Follow-Up Study
Previous Article in Journal
Methods of Airway Resistance Assessment
 
 
Advances in Respiratory Medicine is published by MDPI from Volume 90 Issue 4 (2022). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Via Medica.
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

Tumor Necrosis Factor Alpha as an Asthma Biomarker in Early Childhood

Department of Internal Medicine, Asthma and Allergy, Medical University of Lodz, Łódź, Poland
Adv. Respir. Med. 2016, 84(3), 143-144; https://doi.org/10.5603/PiAP.2016.0015
Submission received: 22 April 2016 / Revised: 28 May 2016 / Accepted: 28 May 2016 / Published: 28 May 2016

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

Research on biomarkers of asthma in early childhood could be explained by at least three reasons [...]

Share and Cite

MDPI and ACS Style

Majak, P. Tumor Necrosis Factor Alpha as an Asthma Biomarker in Early Childhood. Adv. Respir. Med. 2016, 84, 143-144. https://doi.org/10.5603/PiAP.2016.0015

AMA Style

Majak P. Tumor Necrosis Factor Alpha as an Asthma Biomarker in Early Childhood. Advances in Respiratory Medicine. 2016; 84(3):143-144. https://doi.org/10.5603/PiAP.2016.0015

Chicago/Turabian Style

Majak, Paweł. 2016. "Tumor Necrosis Factor Alpha as an Asthma Biomarker in Early Childhood" Advances in Respiratory Medicine 84, no. 3: 143-144. https://doi.org/10.5603/PiAP.2016.0015

Article Metrics

Back to TopTop